2020 has been a challenging year for investors so far. As a result of the coronavirus (Covid-19) outbreak, global economic activity has slumped. This has sent shockwaves through financial markets, with many stocks experiencing double-digit declines. One area of the market that has outperformed, however, is pharmaceutical stocks. Across this sector, share prices have generally held up very well over the last few months. In some cases, they’ve even soared.
It’s not hard to understand why pharmaceutical stocks have outperformed recently. Ultimately, it’s the pharmaceutical sector that is leading the fight against Covid-19.
With that in mind, we have put together this report on major pharmaceutical companies that are working on Covid-19 solutions right now. Could one of these companies be the first to market a vaccine or treatment?
Your capital is at risk